Realeve, LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Unity Ha LLC (to 2022)
11
Ending by 2030
Feb 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 20, 2026The maintenance fee for Systems and methods for improving headache pain (US 11,679,263) comes due Dec 20, 2026. Unpaid by Jun 21, 2027, it lapses early.
- 1 fee due Jun 29, 2027The maintenance fee for Surgical Tools to Facilitate Delivery of a Neurostimulator into the Pterygopalatine Fossa (US 9,220,524) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
- 1 fee due Jul 30, 2027The maintenance fee for Neurostimulators and Related Systems and Methods (US 11,883,665) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
- 1 fee due Oct 26, 2027The maintenance fee for Approval per use implanted neurostimulator (US 9,320,908) comes due Oct 26, 2027. Unpaid by Apr 26, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,686,858 | Patient identification system In force · From the USPTO record | In force | From the USPTO record | |
| US 9,607,195 | Patient identification system In force · From the USPTO record | In force | From the USPTO record | |
| US 8,781,574 | Integrated delivery and visualization tool for a neuromodulation system In force · From the USPTO record | In force | From the USPTO record | |
| US 9,554,694 | Integrated delivery and visualization tool for a neuromodulation system In force · From the USPTO record | In force | From the USPTO record | |
| US 9,604,057 | Stimulation method for a sphenopalatine ganglion, sphenopalatine nerve, vidian nerve, or branch thereof for treatment of medical conditions In force · From the USPTO record | In force | From the USPTO record | |
| US 9,610,441 | Stimulation method for treatment of dermatological conditions In force · From the USPTO record | In force | From the USPTO record | |
| US 8,886,325 | Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism In force · From the USPTO record | In force | From the USPTO record | |
| US 9,550,057 | Surgical Guide and Method for Guiding a Therapy Delivery Device into the Pterygopalatine Fossa In force · Medium confidence | In force | Medium confidence | |
| US 10,286,213 | Neurostimulator system, apparatus, and method In force · From the USPTO record | In force | From the USPTO record | |
| US 9,456,836 | Apparatus and method for delivering a neurostimulator into the pterygopalatine fossa In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 28: 3 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 2 no status recorded